Riskpilot← Back to searchSign inGet full accessBRUMUNDDAL APOTEK AS
ASActiveOrg 927065258Fabrikkvegen 6, 2383 BrumunddalRetail sale of pharmaceutical products · NACE 4773Est. 20210 employees
Revenue 2022
NOK 9,1M
+275% vs 2021
EBITDA margin
-3.0%
+50% vs 2021
Equity ratio
-21.7%
Financial strength
Net profit 2022
NOK -554K
+11% vs 2021
| Revenue | NOK 9,1M | +275% |
| EBITDA | NOK -269K | +50% |
| Net profit | NOK -554K | +11% |
| Total assets | NOK 3,6M | -7% |
| Equity | NOK -779K | -247% |
| Employees | 0 | — |
Legal name
BRUMUNDDAL APOTEK AS
Org number
927065258
Legal form
Aksjeselskap
NACE code
4773 · Retail sale of pharmaceutical products
Founded
4. mai 2021
Share capital
NOK 400 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2022-12-31
Financial year
January – December
Signatory rights
To styremedlemmer i fellesskap.
Company purpose
Eie og drive apotek og alt hva hermed står i forbindelse.
Address
Fabrikkvegen 6, 2383 Brumunddal
Phone
+4762790100
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 |
|---|---|---|
| Revenue | 2 415 | 9 050 |
| Staff expenses | −883 | −2 353 |
| EBITDA | −544 | −269 |
| Depreciation & amort. | −49 | −202 |
| EBIT | −593 | −472 |
| Net financials | −26 | −82 |
| Profit before tax | −619 | −554 |
| Tax | −0 | −0 |
| Net profit | −619 | −554 |
| Item | 2021 | 2022 |
|---|---|---|
| Total assets | 3 868 | 3 585 |
| Equity | −225 | −779 |
| Long-term debt | 1 873 | 1 506 |
| Short-term debt | 2 221 | 2 857 |
| Total debt | 4 093 | 4 364 |
EBITDA margin
-3.0%
This company
15.8%
Market median
-119% vs market
20212022
Equity ratio
-21.7%
This company
38.2%
Market median
-157% vs market
20212022
Return on equity
-55409400.0%
This company
18.4%
Market median
-301138143% vs market
20212022
Net profit margin
-6.1%
This company
8.1%
Market median
-175% vs market
20212022
Asset turnover
2.52×
This company
1.12×
Market median
+125% vs market
20212022
Debt / equity
5.60×
This company
0.62×
Market median
-803% vs market
20212022
| Name | Role | Member since |
|---|---|---|
| Former (1) | ||
AK Chief Executive Officer | Chief Executive Officer | 2021 – 2023 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2023 | |
| Chairman | 2023 | |
| Former (3) | ||
| Chairman | 2021 – 2023 | |
| Board of Directors | 2021 – 2023 | |
| Board of Directors | 2021 – 2023 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2023 | |
| Company | 25% | 25% | 2022 | |
| Company | 25% | 25% | 2022 | |
| Company | 25% | 25% | 2022 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Mckesson Norway Holding As
BRUMUNDDAL APOTEK AS Board members of BRUMUNDDAL APOTEK AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Ashwak Kazem Hamza | Chief Executive Officer | 0 companies |
| Vegard Hoff | Board of Directors | 0 companies |
| Morten Frogner | Chairman | 0 companies |
| Michael Roland Ecker | Chairman | 0 companies |
| Jan Arne Frogner | Board of Directors | 0 companies |
| Einar Mathias Teigen Rasch-Halvorsen | Board of Directors | 0 companies |